THRB and endometrial cancer: Pique and colleagues applied a novel computational tool, receptLoss, to gene expression data from The CancerGenome Atlas (TCGA) and found an association between thyroid hormone receptor beta (THRB) expression loss and increased five-year survival in women with endometrial cancer [32].